The IRAP Treatment for Osteorthritis is now offered by UW/Morrie Waud Equine Center

Here's how it works.

One of the major inducers of osteoarthritis is the general inflammatory molecule IL-1. It's an important part of the inflammatory response, but when it's present in high or prolonged quantities in joints it can be detrimental to the articular cartilage matrix. Treatments currently available to help combat the clinical effects of IL-1 include intra-articular medications, NSAIDS (phenylbutazone or Banamine®), shockwave therapy, Adequan, Legend, and oral supplements.

But a new treatment called IRAP (Interleukin-1 Receptor Antagonist Protein) blocks the IL-1 molecule from binding to tissues, especially damaged articular cartilage in joints.

The procedure begins by drawing blood from the horse into a special glass syringe. The syringe is specifically prepared with glass beads that stimulate the production of the antagonist protein and an anticoagulant. The blood is incubated for 24 hours and then placed in a centrifuge to separate the serum from the blood. The affected joints are then injected with the serum, which may also be frozen for later use.

The IRAP treatment offers the potential to stop cartilage matrix from being degraded and increase healing. Please call us today if you believe that your horse is a candidate for IRAP therapy.